Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer. | Cancers (Basel) | 2023 | 36765579 | PubTator, text mining | PubMed |
| Immune cells drive new immunomodulatory therapies for myocardial infarction: From basic to clinical translation. | Front Immunol | 2023 | 36761726 | PubTator, text mining | PubMed |
| Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment. | Transl Cancer Res | 2023 | 36760385 | PubTator, text mining | PubMed |
| ncRNA-mediated low expression of P2RY14 correlates with poor prognosis and tumor immune infiltration in ovarian carcinoma. | Ann Transl Med | 2023 | 36760244 | PubTator, text mining | PubMed |
| The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentials. | Front Oncol | 2023 | 36756159 | PubTator, text mining | PubMed |
| Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2. | Nat Commun | 2023 | 36755036 | PubTator, text mining | PubMed |
| Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T. | Mol Cancer | 2023 | 36750830 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation. | Immunity | 2023 | 36750099 | PubTator, text mining | PubMed |
| Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases. | Clin Cancer Res | 2023 | 36749885 | PubTator, text mining | PubMed |
| Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes. | Cancer Sci | 2023 | 36748310 | PubTator, text mining | PubMed |
| High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer. | Pathol Oncol Res | 2023 | 36741965 | PubTator, text mining | PubMed |
| PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma. | Sci Rep | 2023 | 36739300 | PubTator, text mining | PubMed |
| A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer. | Comput Struct Biotechnol J | 2023 | 36733702 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy. | Front Immunol | 2023 | 36733484 | PubTator, text mining | PubMed |
| Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis. | Haematologica | 2023 | 36727397 | PubTator, text mining | PubMed |
| Mechanisms underlying pathological scarring by fibroblasts during wound healing. | Int Wound J | 2023 | 36726192 | PubTator, text mining | PubMed |
| Exploring the hub mechanisms of ischemic stroke based on protein-protein interaction networks related to ischemic stroke and inflammatory bowel disease. | Sci Rep | 2023 | 36720935 | PubTator, text mining | PubMed |
| PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma. | Biomed Res Int | 2023 | 36714030 | PubTator, text mining | PubMed |
| EpiMix: an integrative tool for epigenomic subtyping using DNA methylation. | bioRxiv | 2023 | 36711917 | PubTator, text mining | PubMed |
| Gram-Positive Bacteria Cell Wall Peptidoglycan Polymers Activate Human Dendritic Cells to Produce IL-23 and IL-1β and Promote TH17 Cell Differentiation. | Microorganisms | 2023 | 36677464 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=30